{"id":412,"date":"2026-09-23T05:03:18","date_gmt":"2026-09-23T05:03:18","guid":{"rendered":"https:\/\/dentaltransitions.com\/articles\/sell-high-revenue-dso-california\/"},"modified":"2026-09-23T05:03:18","modified_gmt":"2026-09-23T05:03:18","slug":"sell-high-revenue-dso-california","status":"publish","type":"post","link":"https:\/\/dentaltransitions.com\/articles\/sell-high-revenue-dso-california\/","title":{"rendered":"How To Sell Your California Dental Practice to a DSO"},"content":{"rendered":"<h2>Key Takeaways<\/h2>\n<ul>\n<li>\n<p>High-revenue California dental practices with $1.5 million+ in collections can command 9x\u201312x adjusted EBITDA from DSO buyers, though most deals focus on practices above $3 million in collections or $500K+ EBITDA.<\/p>\n<\/li>\n<li>\n<p>DSO screens often emphasize hygiene production above 28\u201335% of collections, provider concentration below 35\u201340% per doctor, and payer mix weighted toward commercial PPO or fee-for-service instead of Medicaid or HMO capitation.<\/p>\n<\/li>\n<li>\n<p>Value in a DSO deal is expressed as a multiple of adjusted EBITDA. DSO buyers do not use a percentage-of-revenue method, so normalizing owner compensation, documenting add-backs, and building a CPA-led diligence-grade EBITDA analysis can be some of the main factors in protecting the headline number.<\/p>\n<\/li>\n<li>\n<p>California\u2019s corporate practice of medicine doctrine requires every DSO deal to run through a PC-MSO structure, which shapes where equity sits, what the seller controls after closing, and how proceeds are taxed at the state level.<\/p>\n<\/li>\n<li>\n<p>McLerran &amp; Associates runs a competitive, auction-style bid process that typically generates around 10 offers and delivers approximately 30% higher valuations than owners achieve selling on their own. See Step 7 for how this process works.<\/p>\n<\/li>\n<\/ul>\n<p><a target=\"_blank\" rel=\"noopener noreferrer nofollow\" class=\"solid-button\" href=\"https:\/\/dentaltransitions.com\/contact-us\/\">Talk With McLerran &amp; Associates About Your California Practice<\/a><\/p>\n<h2>Step 1: Establish What Your California Practice Is Actually Worth<\/h2>\n<p>In a DSO deal, value is expressed as a multiple of adjusted EBITDA. DSO buyers do not use a percentage-of-revenue method. That distinction matters because two practices with identical collections can carry very different EBITDA figures depending on how efficiently each is run. A healthy general dental practice commonly sells for roughly 60\u201385% of annual collections as a rule of thumb, but that method ignores profitability entirely, and institutional buyers instead build their own EBITDA model line by line.<\/p>\n<p>The multiple a practice commands is driven by fundamentals: overall size and collections, number of doctors, expandability, durability of revenue, and the level and quality of EBITDA itself. Those fundamentals sort practices into distinct size tiers, and each tier carries a different multiple range. Single-doctor and add-on practices tend to cluster in a lower multiple range. Associate-led groups with $1 million to $3 million in EBITDA can clear a meaningfully higher range. Platform-grade practices with $3 million or more in EBITDA command the highest multiples among general dental size tiers, with $3M\u2013$5M EBITDA at 9x\u201311x and $5M+ at 10x\u201312x+. Specialty also shapes buyer demand and can move the range, though the exact premium varies by practice and market. (Source: Ad Astra Equity\u2019s 2026 dental practice valuation analysis.)<\/p>\n<p>The EBITDA build starts with the practice\u2019s reported profit, then adds back the owner\u2019s compensation and removes the cost of replacing the owner\u2019s clinical production at a market rate, typically expressed as a percentage of what the owner produces. From there, every discretionary, personal, and non-recurring expense must be unpacked and documented. The most common add-backs buyers scrutinize are family members on payroll at above-market rates, personal vehicle and club memberships, owner-occupied building rent above or below market, and associate-doctor production guarantees paid during ramp-up periods. A weak or unsupported add-back rarely survives a quality-of-earnings review. It usually gets rejected, which reduces the EBITDA the buyer accepts and, at a multiple, compresses enterprise value by a disproportionate amount.<\/p>\n<p>McLerran &amp; Associates builds a CPA-led, diligence-grade EBITDA analysis before any practice goes to market. Because the homework is done up front, the number tends to hold when buyers scrutinize it, and the deal is less likely to get re-traded. For owners weighing both paths, the firm delivers a side-by-side valuation that quantifies the practice\u2019s worth in both the private-buyer and DSO markets. Learn more about the full process McLerran uses to take a practice to market.<\/p>\n<figure style=\"text-align: center;\"><img src=\"https:\/\/cdn.aigrowthmarketer.co\/1782231605342-03c5ed4725a3.jpeg\" alt=\"At McLerran &amp; Associates, every engagement is built on an ironclad, CPA-led EBITDA analysis and practice valuation.\" style=\"max-height: 500px;\" loading=\"lazy\" decoding=\"async\"><figcaption><em>At McLerran &amp; Associates, every engagement is built on an ironclad, CPA-led EBITDA analysis and practice valuation.<\/em><\/figcaption><\/figure>\n<p><a target=\"_blank\" rel=\"noopener noreferrer nofollow\" class=\"solid-button\" href=\"https:\/\/dentaltransitions.com\/contact-us\/\">Get A CPA-Led EBITDA Review For Your Practice<\/a><\/p>\n<h2>Step 2: Know The Rules Of Thumb DSOs Actually Use (50-40-30, 80\/20, And The Two-Year Rule)<\/h2>\n<p>DSOs apply several shorthand screens to quickly assess whether a practice is worth pursuing. Understanding the mechanism behind each one, not just the definition, helps a California owner see what to address before going to market.<\/p>\n<p><strong>The 50-40-30 Rule.<\/strong> This is a dental industry benchmark for optimal practice financial structure: staff costs should not exceed 50% of collections, total overhead should stay below 40%, and doctor compensation should be at least 30% of collections. Note that the rule says nothing about hygiene production, which buyers benchmark separately at roughly 30% to 40% of total net production. When a practice misses the 50-40-30 thresholds, the signal to a buyer is either margin compression or a weak recurring-revenue base, and both factors can justify a lower multiple.<\/p>\n<p><strong>The 80\/20 Rule.<\/strong> In dentistry, this describes provider or production concentration. If roughly 80% of revenue flows through 20% of providers, or if one doctor generates the overwhelming majority of production, the buyer faces key-person risk. Provider concentration is among the single biggest risk factors in dental practice M&amp;A, and a practice where one provider generates 60% or more of collections can face a valuation reduction of 15\u201325% relative to a practice with production distributed across three or more providers. The mechanism is straightforward. When the selling dentist reduces chair time after close, which is common in DSO transitions, a concentrated practice can lose revenue the buyer already paid for.<\/p>\n<p><strong>The Two-Year Rule.<\/strong> DSOs typically want the selling dentist to commit to at least two years of continued clinical employment post-close, and many structures run three to five years. The mechanism is patient retention and revenue continuity. Patient attrition after a change of ownership is a primary post-close risk for DSO buyers, and a longer transition period can reduce that risk. A seller who cannot commit to a meaningful workback often faces a lower offer, a heavier earnout, or both.<\/p>\n<p>Beyond these ratio screens, buyers also test whether earnings are repeatable. A one-time spike in collections from a PPP loan, an Employee Retention Credit, or a one-time insurance settlement usually gets removed from the trailing analysis without discussion.<\/p>\n<p>When a California practice fails one of these screens, the fix is usually operational rather than cosmetic. Normalizing associate production by shifting new patient exams and restorative procedures to associates before going to market reduces provider concentration and builds a documented track record of distributed revenue. Documenting hygiene production with recall compliance data and reappointment rates addresses the hygiene screen. McLerran &amp; Associates identifies these gaps during the valuation phase so owners can address them before a buyer\u2019s diligence team does.<\/p>\n<p><a target=\"_blank\" rel=\"noopener noreferrer nofollow\" class=\"solid-button\" href=\"https:\/\/dentaltransitions.com\/contact-us\/\">Have McLerran Review Your Practice Against DSO Screens<\/a><\/p>\n<h2>Step 3: Structure The Deal Around California\u2019s Corporate Practice Rules<\/h2>\n<p>California\u2019s corporate practice of medicine doctrine, anchored in Business and Professions Code \u00a7 2400, which provides that corporations and other artificial legal entities have no professional rights, privileges, or powers, prohibits non-dentists from owning dental practices outright. This point functions as a first-order economic variable that determines how a California DSO deal is structured, where equity sits, and what the seller controls after closing.<\/p>\n<p>Because unlicensed investors cannot own the clinical practice directly, every California DSO affiliation runs through a professional corporation and management services organization structure, often called the PC-MSO model. The professional corporation (PC), owned by a licensed dentist, holds the clinical practice: the license, the patient relationships, the clinical staff, and the medical records. The management services organization (MSO), owned by the DSO or its private equity backer, holds the non-clinical assets such as equipment, leasehold improvements, and goodwill, and provides administrative and business services under a management services agreement (MSA). The MSA connects the two entities at fair market value.<\/p>\n<p>For the selling dentist, this structure has direct economic consequences. The seller\u2019s proceeds flow primarily from the sale of non-clinical assets to the MSO, rather than from a direct transfer of practice ownership. Where equity sits, either in the joint-venture entity at the practice level or in the holding company at the DSO platform level, determines the seller\u2019s floor, ceiling, and liquidity timeline. JV-level equity typically carries distributions and a higher floor. Holding-company equity carries no distributions but a higher ceiling if the platform recapitalizes at a higher multiple. Those structural choices now carry more regulatory risk than they did a few years ago, because California\u2019s enforcement environment has intensified significantly.<\/p>\n<p>California Senate Bill 351, effective January 1, 2026, authorizes the California Attorney General to investigate and take action against private equity firms and hedge funds that unlawfully interfere in the physician-patient relationship, and declares contract terms violating the statute void and unenforceable. The California Attorney General has brought enforcement actions against major dental management companies in 2026, resulting in settlements that permanently restrict certain MSO contract provisions, including management fees based on revenue, restrictions on where clinicians may practice, and arrangements that effectively transfer practice ownership to the MSO upon termination.<\/p>\n<p>For a California seller, this means the MSA terms require careful review. Provisions that look standard in other states may be unenforceable in California or may even risk voiding the entire arrangement. The same state-specific scrutiny applies to how the practice\u2019s numbers are presented. Worker classification, wage-and-hour compliance, and the treatment of independent contractors are all areas where California\u2019s rules diverge sharply from other states, and a buyer\u2019s diligence team will look closely at each one.<\/p>\n<p>Sellers should consult their own legal and tax advisors on the specific structure of any proposed transaction. McLerran &amp; Associates works alongside qualified dental transaction attorneys and CPAs to help ensure the deal structure is both commercially sound and aligned with California\u2019s evolving regulatory environment.<\/p>\n<p><a target=\"_blank\" rel=\"noopener noreferrer nofollow\" class=\"solid-button\" href=\"https:\/\/dentaltransitions.com\/contact-us\/\">Discuss California PC-MSO Structures With McLerran<\/a><\/p>\n<h2>Step 4: Negotiate The Structure, Not Just The Headline Price<\/h2>\n<p>Structure, not the headline number, is the real decision variable, and in California, structure can be more consequential than in many other markets.<\/p>\n<p>A typical DSO deal combines several components, each with different guarantees, tax treatment, and risk profiles. Cash at close typically represents 60\u201375% of total consideration in DSO dental transactions, tilting toward the higher end for platform-grade practices and toward the lower end for add-on acquisitions carrying heavier rollover components. Only the cash-at-close portion is guaranteed.<\/p>\n<p>Rollover equity, the portion of proceeds the seller keeps as an ownership stake in the DSO rather than taking as cash, is effectively mandatory in most DSO deals and typically runs 15\u201330% of total consideration. Because that equity is illiquid, its value depends entirely on the DSO\u2019s performance, and it cannot be monetized until the platform recapitalizes or sells, a timeline that commonly runs three to seven years. In some deals, equity can account for as much as roughly 40% of total consideration, which means the seller is effectively underwriting the DSO as an investment. A seller should assess the DSO\u2019s profitability, growth at existing offices, management strength, and the track record of its private equity backer before accepting a large equity component.<\/p>\n<p>Earnout provisions, which are contingent payments tied to the practice hitting specified performance targets in the 12 to 36 months after closing, represent one of the most negotiable and most misunderstood components of a DSO deal. Non-punitive earnout terms matter. A pro-rata provision that pays most of the earnout even on a near-miss, or a later start date that accounts for integration disruption, can be worth hundreds of thousands of dollars over the workback period. Punitive earnout structures that claw back proceeds if production dips below a threshold the seller does not fully control are among the most common sources of post-close regret.<\/p>\n<p>The workback, meaning the post-close employment period during which the selling dentist continues practicing, typically involves a minimum five-year working agreement on a DSO deal, though a shorter workback may be possible if the dentist has already worked mostly out of the chair. During that period, the seller\u2019s compensation shifts from owner distributions to a clinical salary, typically expressed as a percentage of personal collections. That shift represents a meaningful income reduction that should be modeled across the full workback period before comparing offers.<\/p>\n<p>California presents a specific cash-at-close challenge. California taxes capital gains as ordinary income with no preferential rate, at a top marginal state rate of 13.3%, plus a 1% Mental Health Services Tax on gains over $1 million. Combined with federal long-term capital gains rates and the Net Investment Income Tax, a lump-sum California dental practice sale can result in roughly 38% of the gain going to combined federal and state tax in year one. Knowing which buyers are cash-heavy in the California market, and structuring the deal to maximize the portion treated at long-term capital gains rates rather than ordinary income, can materially affect what the seller keeps. Sellers should consult their own tax advisors on the specific treatment of each deal component.<\/p>\n<p><a target=\"_blank\" rel=\"noopener noreferrer nofollow\" class=\"solid-button\" href=\"https:\/\/dentaltransitions.com\/contact-us\/\">Model Your Deal Structure And After-Tax Proceeds<\/a><\/p>\n<h2>Step 5: Compare The DSO Path Against A Private Sale In California<\/h2>\n<p>Owners of California practices in the $1.5 million to $3 million revenue range often have a real choice between a DSO sale and a private doctor-to-doctor sale. The right path depends on the owner\u2019s goals, timeline, and tolerance for contingent value.<\/p>\n<p>A private sale to another dentist typically offers greater cash certainty at close, a shorter workback of roughly four to eight weeks, and a cleaner exit from the business of running a practice. The buyer is a licensed dentist who owns and operates the clinical entity outright, with no PC-MSO structure, no rollover equity, and no earnout tied to a corporate parent\u2019s performance. The trade-off is that individual buyers generally cannot match the enterprise value a competitive DSO process can generate, particularly for practices above $1.5 million in collections where DSO demand can be structural.<\/p>\n<p>A DSO affiliation can generate a materially higher headline number, access to platform infrastructure, and a potential \u201csecond bite of the apple\u201d through rollover equity if the DSO recapitalizes at a higher multiple. The trade-offs include a longer workback, reduced clinical autonomy under a corporate employment agreement, income that shifts from owner distributions to a clinical salary, and equity that is illiquid and dependent on a platform the seller no longer controls.<\/p>\n<p>Tax treatment differs by path as well. In a DSO deal, much of the proceeds, particularly the goodwill component, which typically represents 76% or more of the purchase price in a dental practice sale, can be treated at long-term capital gains rates rather than ordinary income at the federal level. Sellers should consult their own tax advisors on the specific allocation and California treatment of each component.<\/p>\n<p>McLerran &amp; Associates works both paths in roughly equal measure, approximately 50% private-buyer and 50% DSO transactions, and produces a side-by-side valuation that quantifies the practice\u2019s worth in both markets. The firm also prepares multi-year, multi-structure financial forecasting across three-, five-, seven-, and ten-year horizons. That comparison can form the foundation of an informed decision. Learn more about <a target=\"_blank\" rel=\"noindex nofollow\" href=\"https:\/\/dentaltransitions.com\/how-to-maximize-the-value-of-your-dental-practice\/\">how to maximize the value of your dental practice<\/a> before going to market on either path.<\/p>\n<p><a target=\"_blank\" rel=\"noopener noreferrer nofollow\" class=\"solid-button\" href=\"https:\/\/dentaltransitions.com\/contact-us\/\">Request A Side-By-Side DSO Vs. Private Sale Analysis<\/a><\/p>\n<h2>Step 6: Vet The Buyer Like An Investment<\/h2>\n<p>A DSO offer functions as both a purchase price and a multi-year partnership with a corporate entity. That entity\u2019s financial health, management quality, and private equity backing can directly determine whether the seller\u2019s rollover equity has value at the end of the workback.<\/p>\n<p>Post-close realities that can surprise sellers include reduced clinical autonomy under regional managers and standardized protocols, a shift in case mix toward procedures the DSO wants to scale, staff turnover in the first 12 to 18 months as the culture changes, and earnout targets that prove difficult to hit during the integration period. These outcomes occur frequently when sellers choose a buyer based on headline price alone.<\/p>\n<p>The rollover equity component deserves particular scrutiny. Highly leveraged DSO platforms, meaning those carrying significant debt relative to EBITDA, have limited margin for error, and several DSO platforms have filed for bankruptcy or undergone debt restructuring since 2022. A seller who rolls 20% to 30% of proceeds into a platform that later struggles may recover little or nothing on that portion of the deal. Sellers should treat rollover equity as a speculative, illiquid asset and stress-test their retirement plans against scenarios where it is worth zero.<\/p>\n<p>That kind of stress-testing starts with the buyer. McLerran &amp; Associates vets buyers like investments, assessing profitability, same-store growth, management depth, and the track record of the private equity backer, and has blacklisted DSOs known for creating poor post-close environments. Poorly run buyers never reach the table. The firm negotiates non-punitive earnout provisions and optimizes for both price and fit so the practice\u2019s legacy, patients, and staff are considered alongside the seller\u2019s financial outcome.<\/p>\n<p><a target=\"_blank\" rel=\"noopener noreferrer nofollow\" class=\"solid-button\" href=\"https:\/\/dentaltransitions.com\/contact-us\/\">Have McLerran Vet Potential DSO Buyers For You<\/a><\/p>\n<h2>Step 7: Run A Competitive Process And Defend The Number<\/h2>\n<p>A practice owner who negotiates directly with a single DSO usually negotiates from a weak position. A DSO negotiates deals every week, while a practice owner may sell once in a career. Without competitive tension, the buyer sets the terms of the conversation, and the valuation anchor quietly determines what the seller walks away with.<\/p>\n<p>McLerran &amp; Associates runs a structured, auction-like bid process that typically spans 45 to 60 days and generates around 10 offers from a vetted pool of well-qualified buyers. That competition can push the price up and move the terms toward the seller. The firm\u2019s clients receive, on average, approximately 30% higher valuations than owners achieve selling on their own, according to McLerran &amp; Associates\u2019 own figures.<\/p>\n<p>After a letter of intent is signed, the real work begins: defending the EBITDA through the buyer\u2019s quality-of-earnings review. Roughly 85% of lower-middle-market dental deals see a post-LOI price adjustment during the quality-of-earnings audit. A valuation analysis that cannot support its add-backs with documentation often gets re-traded. McLerran\u2019s CPA-led EBITDA analysis is built to withstand that scrutiny, and the firm\u2019s advisors defend the agreed value through diligence, reminding buyers that other vetted bidders are waiting if they attempt to trade the deal down.<\/p>\n<p><a target=\"_blank\" rel=\"noopener noreferrer nofollow\" class=\"solid-button\" href=\"https:\/\/dentaltransitions.com\/contact-us\/\">Learn How McLerran Runs A Competitive Sale Process<\/a><\/p>\n<h2>Why California Owners Choose McLerran &amp; Associates<\/h2>\n<p>McLerran &amp; Associates is a dental-only, sell-side advisory firm that represents the seller, not the buyer. Every engagement rests on the same foundation: a CPA-led, diligence-grade EBITDA analysis, a competitive bid process among a vetted buyer pool, and advocacy through every stage of the transaction.<\/p>\n<p>The firm\u2019s track record, according to McLerran &amp; Associates\u2019 own figures, includes approximately 2,000 successful practice sales, about $2 billion in closed transaction volume, more than 10,000 practices evaluated, roughly 35 years in business, and more than 100 years of collective dental-industry experience across a team of former investment bankers, practice-finance lenders, DSO buyers, CPAs, and advisors. The firm\u2019s transaction rate runs roughly 85\u201390%, compared to an industry norm closer to 35\u201340%, and its clients benefit from the 30% valuation premium described in Step 7.<\/p>\n<figure style=\"text-align: center;\"><img src=\"https:\/\/cdn.aigrowthmarketer.co\/1782231581955-2aa75d9d4697.jpeg\" alt=\"McLerran &amp; Associates team: McLerran is the nation's largest dental-specific sell-side M&amp;A advisory and brokerage firms\" style=\"max-height: 500px;\" loading=\"lazy\" decoding=\"async\"><figcaption><em>McLerran &amp; Associates team: McLerran is the nation&#8217;s largest dental-specific sell-side M&amp;A advisory and brokerage firms<\/em><\/figcaption><\/figure>\n<p>Because McLerran works both the private-buyer and DSO paths in roughly equal measure, approximately a 50\/50 split, it produces a genuine side-by-side comparison that single-lane brokers cannot. Owners in the $1.5 million to $3 million revenue range often benefit most from this dual-path capability because the right answer is rarely obvious without running both valuations.<\/p>\n<p>California owners work directly with the firm\u2019s Los Angeles office, led by Steven Au. McLerran also maintains offices in Cleveland (led by Justin Klingshim), Atlanta (led by Matt Sutton), Northern Virginia (led by Andrew Kobylski), and Phoenix (led by Brian Carroll, covering the Mountain West).<\/p>\n<figure style=\"text-align: center;\"><img src=\"https:\/\/cdn.aigrowthmarketer.co\/1782231776232-426cf610db07.jpeg\" alt=\"A chat at McLerran &amp; Associates: the dental-specific sell-side advisor and advocate for practice owners guides on how, when, and to whom to sell your practice.\" style=\"max-height: 500px;\" loading=\"lazy\" decoding=\"async\"><figcaption><em>A chat at McLerran &amp; Associates: the dental-specific sell-side advisor and advocate for practice owners guides on how, when, and to whom to sell your practice.<\/em><\/figcaption><\/figure>\n<p>For owners who have not yet decided whether to sell, or who want to get educated before committing to any path, McLerran hosts the McLerran M&amp;A Summit on October 29\u201330, 2026, a dental-only event featuring expert panels, one-on-one CPA sessions, 4 CE credits, and a complimentary practice valuation (a $2,500 value).<\/p>\n<p><a target=\"_blank\" rel=\"noopener noreferrer nofollow\" class=\"solid-button\" href=\"https:\/\/dentaltransitions.com\/contact-us\/\">Connect With McLerran\u2019s California Advisory Team<\/a><\/p>\n<h2>Frequently Asked Questions<\/h2>\n<h3>How Much Can You Sell A High-Revenue California Dental Practice For?<\/h3>\n<p>Value in a DSO deal is expressed as a multiple of adjusted EBITDA. DSO buyers do not use a percentage-of-revenue method. The multiple a practice commands can depend on fundamentals such as overall size and collections, number of doctors, expandability, durability of revenue, payer mix, hygiene production as a share of total collections, and how much of the practice\u2019s revenue is tied to the selling dentist personally. Larger, associate-led, multi-location practices with clean financials and strong hygiene departments tend to command higher multiples than smaller, owner-dependent practices. Specialty can also move the range. In California, the PC-MSO structure, the cash-at-close percentage, the earnout terms, and the state\u2019s tax treatment of each component can be some of the main factors in determining what the seller actually keeps. A comprehensive, CPA-led valuation can help establish a defensible number before going to market.<\/p>\n<h3>What Is The 50-40-30 Rule In Dentistry?<\/h3>\n<p>The 50-40-30 rule is a dental industry benchmark for optimal practice financial structure: staff costs should not exceed 50% of collections, total overhead should stay below 40%, and doctor compensation should be at least 30% of collections. As noted in Step 2, it does not benchmark hygiene production, which is measured separately. A practice that runs staff costs above roughly 50% of collections or total overhead above roughly 40% often signals margin compression, and DSOs pay close attention to those figures when they underwrite durable, transferable earnings.<\/p>\n<h3>What Is The Two-Year Rule For Dentists?<\/h3>\n<p>The two-year rule refers to the minimum post-close employment commitment most DSOs require from a selling dentist. As Step 2 explains, the mechanism centers on patient retention and revenue continuity, because a longer transition period can reduce attrition risk and support the revenue the buyer paid for.<\/p>\n<h3>Can A California DSO Own My Dental Practice Outright?<\/h3>\n<p>California\u2019s corporate practice of medicine doctrine, codified in Business and Professions Code \u00a7 2400 and related statutes, prohibits non-dentists from owning dental practices outright. Only a licensed dentist or a registered dental corporation owned by licensed dentists may hold the clinical practice entity. As a result, every California DSO affiliation runs through the PC-MSO structure described in Step 3: the dentist-owned professional corporation holds the clinical practice, and the DSO-owned management services organization holds the non-clinical assets. California\u2019s enforcement of this doctrine has intensified significantly in 2026, with the state Attorney General bringing enforcement actions against major dental management companies and securing settlements that restrict specific MSO contract provisions. Sellers should consult their own legal and tax advisors on the specific structure of any proposed transaction before signing any agreement.<\/p>\n<h2>Conclusion: Control The Narrative Around Your EBITDA<\/h2>\n<p>Structure and compliance, not just the headline number, determine what you actually keep in a California DSO sale. A high-revenue practice that goes to market with a defensible EBITDA, a competitive bid process, and the right PC-MSO structure can often keep materially more than one that negotiates alone or accepts the first offer on the table.<\/p>\n<p>McLerran &amp; Associates positions itself as a focused sell-side resource for high-revenue California dental practice owners. The firm\u2019s dental-only focus, CPA-led valuation, vetted buyer pool, and structured competitive process are designed for this type of transition, which is often the biggest financial decision of a dentist\u2019s career and is negotiated against buyers who do this every week.<\/p>\n<p><a target=\"_blank\" rel=\"noopener noreferrer nofollow\" class=\"solid-button\" href=\"https:\/\/dentaltransitions.com\/contact-us\/\">Start A Confidential Conversation About Your Exit Options<\/a><\/p>\n<h2>Read Next<\/h2>\n<ul>\n<li>\n<p><a target=\"_blank\" rel=\"noopener noreferrer nofollow\" href=\"https:\/\/dentaltransitions.com\/articles\/selling-dso-california-process-steps\">How to Sell Your CA Dental Practice to a DSO: 11 Steps<\/a><\/p>\n<\/li>\n<li>\n<p><a target=\"_blank\" rel=\"noopener noreferrer nofollow\" href=\"https:\/\/dentaltransitions.com\/articles\/maximize-practice-value-dso-california\">Maximize Dental Practice Value for a DSO Sale in California<\/a><\/p>\n<\/li>\n<li>\n<p><a target=\"_blank\" rel=\"noopener noreferrer nofollow\" href=\"https:\/\/dentaltransitions.com\/articles\/compare-dso-offers-california-dental\">How to Compare DSO Offers for Your California Practice<\/a><\/p>\n<\/li>\n<li>\n<p><a target=\"_blank\" rel=\"noopener noreferrer nofollow\" href=\"https:\/\/dentaltransitions.com\/articles\/dso-vs-private-sale-california\">DSO vs. Private Sale Dental Practice California: 2026 Guide<\/a><\/p>\n<\/li>\n<li>\n<p><a target=\"_blank\" rel=\"noopener noreferrer nofollow\" href=\"https:\/\/dentaltransitions.com\/articles\/sell-dental-practice-to-dso\">How to Sell Your Dental Practice to a DSO<\/a><\/p>\n<\/li>\n<\/ul>\n","protected":false},"excerpt":{"rendered":"<p>Maximize your DSO sale in California. McLerran &#038; Associates helps dental practice owners navigate valuation, deal structure, and what you keep.<\/p>\n","protected":false},"author":1,"featured_media":411,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"inline_featured_image":false,"footnotes":""},"categories":[1],"tags":[],"class_list":["post-412","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-uncategorized"],"_links":{"self":[{"href":"https:\/\/dentaltransitions.com\/articles\/wp-json\/wp\/v2\/posts\/412","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/dentaltransitions.com\/articles\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/dentaltransitions.com\/articles\/wp-json\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/dentaltransitions.com\/articles\/wp-json\/wp\/v2\/comments?post=412"}],"version-history":[{"count":0,"href":"https:\/\/dentaltransitions.com\/articles\/wp-json\/wp\/v2\/posts\/412\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/dentaltransitions.com\/articles\/wp-json\/wp\/v2\/media\/411"}],"wp:attachment":[{"href":"https:\/\/dentaltransitions.com\/articles\/wp-json\/wp\/v2\/media?parent=412"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/dentaltransitions.com\/articles\/wp-json\/wp\/v2\/categories?post=412"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/dentaltransitions.com\/articles\/wp-json\/wp\/v2\/tags?post=412"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}